Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland
Maarit K. Leinonen(University of Helsinki), Ahti Anttila(Finnish Cancer Registry), Pirkka‐Pekka Laurila(École Polytechnique Fédérale de Lausanne), Arun Pokhrel(Finnish Cancer Registry), Nea Malila(Istituto Superiore di Sanità), Pekka Nieminen(University of Helsinki), Jussi Tarkkanen, M Hakama(Finnish Cancer Registry), Stefan Lönnberg(Finnish Cancer Registry)
Cited by 111
Related Papers
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study
|The Lancet Oncology|2017|510
Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study
|European Journal of Cancer|2015|486
Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study
|The Lancet Oncology|2021|477
Survival of women with cancers of breast and genital organs in Europe 1999–2007: Results of the EUROCARE-5 study
|European Journal of Cancer|2015|279
Age-Specific Evaluation of Primary Human Papillomavirus Screening vs Conventional Cytology in a Randomized Setting
|JNCI Journal of the National Cancer Institute|2009|265